<DOC>
	<DOC>NCT00384592</DOC>
	<brief_summary>The purpose of this study is to assess how patients with gastro-oesophageal reflux disease (heartburn) who are currently receiving treatment with a proton pump inhibitor but are still experiencing symptoms will benefit from a change in treatment.</brief_summary>
	<brief_title>PPI Sequencing Study</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Persisting symptoms of GORD despite previous treatment with a full dose proton pump inhibitor Informed consent Over 18 years of age Current course of Proton Pump inhibitor treatment for more than 8 weeks prior to enrolment in the study; More than 1 other course of PPI treatment in the previous 12 month; Previous use of esomeprazole; Presence of alarm symptoms.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>heartburn</keyword>
	<keyword>reflux</keyword>
	<keyword>proton pump inhibitor</keyword>
	<keyword>GERD</keyword>
	<keyword>GORD</keyword>
</DOC>